AAAAAA

   
Results: 1-17 |
Results: 17
EMERGING ROLE OF AROMATASE INHIBITORS IN THE TREATMENT OF BREAST-CANCER
Authors: HARVEY HA
Citation: Ha. Harvey, EMERGING ROLE OF AROMATASE INHIBITORS IN THE TREATMENT OF BREAST-CANCER, Oncology, 12(3), 1998, pp. 32-35
PHASE-I STUDY COMBINING TUMOR-NECROSIS-FACTOR WITH INTERFERON-ALPHA AND INTERLEUKIN-2
Authors: ESKANDER ED HARVEY HA GIVANT E LIPTON A
Citation: Ed. Eskander et al., PHASE-I STUDY COMBINING TUMOR-NECROSIS-FACTOR WITH INTERFERON-ALPHA AND INTERLEUKIN-2, American journal of clinical oncology, 20(5), 1997, pp. 511-514
ULTRASTRUCTURAL ANALYSIS OF PRIMARY HUMAN URETHRAL EPITHELIAL-CELL CULTURES INFECTED WITH NEISSERIA-GONORRHOEAE
Authors: HARVEY HA KETTERER MR PRESTON A LUBAROFF D WILLIAMS R APICELLA MA
Citation: Ha. Harvey et al., ULTRASTRUCTURAL ANALYSIS OF PRIMARY HUMAN URETHRAL EPITHELIAL-CELL CULTURES INFECTED WITH NEISSERIA-GONORRHOEAE, Infection and immunity, 65(6), 1997, pp. 2420-2427
ISSUES CONCERNING THE ROLE OF CHEMOTHERAPY AND HORMONAL-THERAPY OF BONE METASTASES FROM BREAST-CARCINOMA
Authors: HARVEY HA
Citation: Ha. Harvey, ISSUES CONCERNING THE ROLE OF CHEMOTHERAPY AND HORMONAL-THERAPY OF BONE METASTASES FROM BREAST-CARCINOMA, Cancer, 80(8), 1997, pp. 1646-1651
THE ROLE OF BISPHOSPHONATES IN THE TREATMENT OF BONE METASTASES - THEUS EXPERIENCE
Authors: HARVEY HA LIPTON A
Citation: Ha. Harvey et A. Lipton, THE ROLE OF BISPHOSPHONATES IN THE TREATMENT OF BONE METASTASES - THEUS EXPERIENCE, Supportive care in cancer, 4(3), 1996, pp. 213-217
THE IMPACT OF 2D VERSUS 3D QUANTITATION OF TUMOR BULK DETERMINATION ON CURRENT METHODS OF ASSESSING RESPONSE TO TREATMENT
Authors: HOPPER KD KASALES CJ EGGLI KD TENHAVE TR BELMAN NM POTOK PS VANSLYKE MA OLT GJ CLOSE P LIPTON A HARVEY HA HARTZEL JS
Citation: Kd. Hopper et al., THE IMPACT OF 2D VERSUS 3D QUANTITATION OF TUMOR BULK DETERMINATION ON CURRENT METHODS OF ASSESSING RESPONSE TO TREATMENT, Journal of computer assisted tomography, 20(6), 1996, pp. 930-937
GROWTH-INHIBITION OF BREAST-CANCER CELL-LINES BY COMBINATIONS OF ANTI-P185(HER2) MONOCLONAL-ANTIBODY AND CYTOKINES
Authors: KOPRESKI MS LIPTON A HARVEY HA KUMAR R
Citation: Ms. Kopreski et al., GROWTH-INHIBITION OF BREAST-CANCER CELL-LINES BY COMBINATIONS OF ANTI-P185(HER2) MONOCLONAL-ANTIBODY AND CYTOKINES, Anticancer research, 16(1), 1996, pp. 433-436
PHASE-I TRIAL OF RECOMBINANT PLATELET FACTOR-4 (RPF4) IN PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA
Authors: BELMAN N BONNEM EM HARVEY HA LIPTON A
Citation: N. Belman et al., PHASE-I TRIAL OF RECOMBINANT PLATELET FACTOR-4 (RPF4) IN PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA, Investigational new drugs, 14(4), 1996, pp. 387-389
AROMATASE INHIBITORS IN CLINICAL-PRACTICE - CURRENT STATUS AND A LOOKTO THE FUTURE
Authors: HARVEY HA
Citation: Ha. Harvey, AROMATASE INHIBITORS IN CLINICAL-PRACTICE - CURRENT STATUS AND A LOOKTO THE FUTURE, Seminars in oncology, 23(4), 1996, pp. 33-38
EPIDERMAL GROWTH-FACTOR RECEPTOR ECTODOMAIN IN THE URINE OF PATIENTS WITH SQUAMOUS-CELL CARCINOMA
Authors: WITTERS LM CURLEY EM KUMAR R CHINCHILLI VM HARVEY JP CREBBIN V HARVEY HA LIPTON A
Citation: Lm. Witters et al., EPIDERMAL GROWTH-FACTOR RECEPTOR ECTODOMAIN IN THE URINE OF PATIENTS WITH SQUAMOUS-CELL CARCINOMA, Clinical cancer research, 1(5), 1995, pp. 551-557
THE MANAGEMENT OF HYPERCALCEMIA OF MALIGNANCY
Authors: HARVEY HA
Citation: Ha. Harvey, THE MANAGEMENT OF HYPERCALCEMIA OF MALIGNANCY, Supportive care in cancer, 3(2), 1995, pp. 123-129
SIZE-SPECIFIC FISH AVOIDANCE OF THE SPINED CRUSTACEAN BYTHOTREPHES - FIELD SUPPORT FOR LABORATORY PREDICTIONS
Authors: BARNHISEL DR HARVEY HA
Citation: Dr. Barnhisel et Ha. Harvey, SIZE-SPECIFIC FISH AVOIDANCE OF THE SPINED CRUSTACEAN BYTHOTREPHES - FIELD SUPPORT FOR LABORATORY PREDICTIONS, Canadian journal of fisheries and aquatic sciences, 52(4), 1995, pp. 768-775
OVARIAN-CANCER - SCREENING, TREATMENT, AND FOLLOW-UP
Authors: SELTZER V BATSON JL DRUKKER BH GILLESPIE BW GOSSFELD LM GRIGSBY PW HARVEY HA HENDRICKS CB HUMMEL S MAKUCH RW MONACO GP PARHAM GP SAWYERS CL WEST RJ
Citation: V. Seltzer et al., OVARIAN-CANCER - SCREENING, TREATMENT, AND FOLLOW-UP, JAMA, the journal of the American Medical Association, 273(6), 1995, pp. 491-497
LETROZOLE (CGS-20267) - A PHASE-I STUDY OF A NEW POTENT ORAL AROMATASE INHIBITOR OF BREAST-CANCER
Authors: LIPTON A DEMERS LM HARVEY HA KAMBIC KB GROSSBERG H BRADY C ADLERCRUETZ H TRUNET PF SANTEN RJ
Citation: A. Lipton et al., LETROZOLE (CGS-20267) - A PHASE-I STUDY OF A NEW POTENT ORAL AROMATASE INHIBITOR OF BREAST-CANCER, Cancer, 75(8), 1995, pp. 2132-2138
GROWTH-INHIBITION OF HUMAN MAMMARY-CARCINOMA CELL-LINES BY COMBINATIONS OF ANTI-P185(HER2) MAB AND CYTOKINES
Authors: KOPRESKI MS LIPTON A HARVEY HA KUMAR R
Citation: Ms. Kopreski et al., GROWTH-INHIBITION OF HUMAN MAMMARY-CARCINOMA CELL-LINES BY COMBINATIONS OF ANTI-P185(HER2) MAB AND CYTOKINES, Clinical research, 42(2), 1994, pp. 10000127-10000127
THE EFFECTS OF LONG-TERM FADROZOLE HYDROCHLORIDE TREATMENT IN PATIENTS WITH ADVANCED STAGE BREAST-CANCER
Authors: DEMERS LM LIPTON A HARVEY HA HANAGAN J MULAGHA M SANTEN RJ
Citation: Lm. Demers et al., THE EFFECTS OF LONG-TERM FADROZOLE HYDROCHLORIDE TREATMENT IN PATIENTS WITH ADVANCED STAGE BREAST-CANCER, Journal of steroid biochemistry and molecular biology, 44(4-6), 1993, pp. 683-685
THE EFFICACY OF CGS-20267 IN SUPPRESSING ESTROGEN BIOSYNTHESIS IN PATIENTS WITH ADVANCED STAGE BREAST-CANCER
Authors: DEMERS LM LIPTON A HARVEY HA KAMBIC KB GROSSBERG H BRADY C SANTEN RJ
Citation: Lm. Demers et al., THE EFFICACY OF CGS-20267 IN SUPPRESSING ESTROGEN BIOSYNTHESIS IN PATIENTS WITH ADVANCED STAGE BREAST-CANCER, Journal of steroid biochemistry and molecular biology, 44(4-6), 1993, pp. 687-691
Risultati: 1-17 |